Boekhout AH, Rogiers A, Jozwiak K, Boers-Sonderen MJ, van den Eertwegh AJ, Hospers GA, et al. Health-related quality of life of long-term advanced melanoma survivors treated with anti-CTLA-4 immune checkpoint inhibition compared to matched controls. AO [Internet]. 2021 Jan. 2 [cited 2025 Feb. 21];60(1):69-77. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/21371